CELU
Price
$1.85
Change
-$0.06 (-3.14%)
Updated
Jun 27 closing price
Capitalization
44.31M
CYBN
Price
$8.15
Change
-$0.43 (-5.01%)
Updated
Jun 27 closing price
Capitalization
179.39M
Interact to see
Advertisement

CELU vs CYBN

Header iconCELU vs CYBN Comparison
Open Charts CELU vs CYBNBanner chart's image
Celularity
Price$1.85
Change-$0.06 (-3.14%)
Volume$19.96K
Capitalization44.31M
Cybin
Price$8.15
Change-$0.43 (-5.01%)
Volume$184.17K
Capitalization179.39M
CELU vs CYBN Comparison Chart in %
Loading...
CELU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYBN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CELU vs. CYBN commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELU is a Buy and CYBN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (CELU: $1.85 vs. CYBN: $8.15)
Brand notoriety: CELU and CYBN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELU: 27% vs. CYBN: 64%
Market capitalization -- CELU: $44.31M vs. CYBN: $173.36M
CELU [@Biotechnology] is valued at $44.31M. CYBN’s [@Biotechnology] market capitalization is $173.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELU’s FA Score shows that 0 FA rating(s) are green whileCYBN’s FA Score has 1 green FA rating(s).

  • CELU’s FA Score: 0 green, 5 red.
  • CYBN’s FA Score: 1 green, 4 red.
According to our system of comparison, CYBN is a better buy in the long-term than CELU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELU’s TA Score shows that 3 TA indicator(s) are bullish while CYBN’s TA Score has 3 bullish TA indicator(s).

  • CELU’s TA Score: 3 bullish, 6 bearish.
  • CYBN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CYBN is a better buy in the short-term than CELU.

Price Growth

CELU (@Biotechnology) experienced а +5.11% price change this week, while CYBN (@Biotechnology) price change was +4.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYBN($179M) has a higher market cap than CELU($44.3M). CYBN YTD gains are higher at: -7.596 vs. CELU (-11.058). CELU has higher annual earnings (EBITDA): -21.59M vs. CYBN (-134.52M). CYBN has more cash in the bank: 136M vs. CELU (133K). CYBN has less debt than CELU: CYBN (0) vs CELU (69.1M). CELU has higher revenues than CYBN: CELU (48.2M) vs CYBN (0).
CELUCYBNCELU / CYBN
Capitalization44.3M179M25%
EBITDA-21.59M-134.52M16%
Gain YTD-11.058-7.596146%
P/E RatioN/AN/A-
Revenue48.2M0-
Total Cash133K136M0%
Total Debt69.1M0-
FUNDAMENTALS RATINGS
CELU: Fundamental Ratings
CELU
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CELUCYBN
RSI
ODDS (%)
Bearish Trend 3 days ago
68%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 17 days ago
81%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
CELU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYBN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PPZRF0.01N/A
N/A
SEASIF EXPLORATION INC.
WFRSF1.58N/A
N/A
West African Resources Ltd.
FLMNY12.80N/A
N/A
Fielmann Group AG
PXCLF0.03N/A
N/A
Phoenix Copper Limited
NOKBF5.02-0.01
-0.20%
Nokia Corp.

CELU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELU has been loosely correlated with ACOG. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CELU jumps, then ACOG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELU
1D Price
Change %
CELU100%
-3.14%
ACOG - CELU
48%
Loosely correlated
-1.14%
NVCT - CELU
27%
Poorly correlated
-2.08%
CYBN - CELU
26%
Poorly correlated
-5.01%
SPRO - CELU
26%
Poorly correlated
+1.38%
OTLK - CELU
25%
Poorly correlated
-8.57%
More

CYBN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYBN has been loosely correlated with ATAI. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CYBN jumps, then ATAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYBN
1D Price
Change %
CYBN100%
-5.01%
ATAI - CYBN
46%
Loosely correlated
-2.22%
ABSI - CYBN
39%
Loosely correlated
-3.32%
RXRX - CYBN
39%
Loosely correlated
-6.85%
ABCL - CYBN
39%
Loosely correlated
-3.48%
EYPT - CYBN
35%
Loosely correlated
-7.04%
More